MindBio Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Cash & Equivalents	0.07	0.06	0.14	0.32	1.31
Short-Term Investments	-	-	-	0.01	0.03
Cash & Short-Term Investments	0.07	0.06	0.14	0.33	1.35
Cash Growth	374.40%	-53.83%	-58.48%	-75.22%	-
Other Receivables	1.12	0.05	0.06	0.05	0.05
Receivables	1.12	0.05	0.06	0.05	0.05
Restricted Cash	-	-	-	0.28	0.22
Total Current Assets	1.19	0.12	0.19	0.67	1.61
Total Assets	1.19	0.12	0.19	0.67	1.61
Accounts Payable	0.17	0.17	0.23	0.57	0.05
Accrued Expenses	0.11	0.15	0.08	0.08	1.15
Current Portion of Long-Term Debt	2.24	2.24	4.98	2.16	-
Current Unearned Revenue	-	-	-	0.12	-
Total Current Liabilities	2.52	2.56	5.29	2.93	1.19
Long-Term Debt	-	-	-	2.82	4.5
Other Long-Term Liabilities	-	-	0.31	0.35	0.15
Total Liabilities	2.52	2.56	5.6	6.09	5.84
Common Stock	15.84	10.68	5.48	5.37	4.51
Retained Earnings	-20.97	-15.29	-12.49	-12.38	-8.74
Comprehensive Income & Other	1.76	2.22	1.65	1.65	-
Total Common Equity	-1.27	-2.38	-5.35	-5.36	-4.23
Minority Interest	-0.06	-0.06	-0.05	-0.06	-
Shareholders' Equity	-1.33	-2.44	-5.41	-5.42	-4.23
Total Liabilities & Equity	1.19	0.12	0.19	0.67	1.61
Total Debt	2.24	2.24	4.98	4.97	4.5
Net Cash (Debt)	-2.17	-2.18	-4.84	-4.64	-3.15
Net Cash Per Share	-0.35	-4.24	-14.54	-16.85	-23.57
Filing Date Shares Outstanding	7.28	2.01	0.34	0.33	0.13
Total Common Shares Outstanding	7.28	1.42	0.34	0.33	0.13
Working Capital	-1.33	-2.44	-5.1	-2.25	0.42
Book Value Per Share	-0.17	-1.68	-15.85	-16.11	-31.64
Tangible Book Value	-1.27	-2.38	-5.35	-5.36	-4.23
Tangible Book Value Per Share	-0.17	-1.68	-15.85	-16.11	-31.64